The Transcriptomic Study of Thai Patients With Atopic Dermatitis by Tape Strips

NCT ID: NCT05598762

Last Updated: 2022-11-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-12-31

Study Completion Date

2024-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will be use the tape strip technique to evaluate the skin biomarkers of atopic dermatitis among Thai patients to differentiate clinical phenotype.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The patients will be enrolled in this study if they have been diagnosed with atopic dermatitis. All participants (AD patients and controls) will be evaluated their skin biomarkers by using tape stripping. The tape strips will be applied to the antecubital fossa to collect the epithelial samples. Then RNA was extracted from the tape strips for mRNA profiling to identify the immune and epidermal barrier genes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atopic Dermatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Children with mild atopic dermatitis

* age 1-8 years old
* mild degree of atopic dermatitis

Group Type ACTIVE_COMPARATOR

Tape strips

Intervention Type GENETIC

Tape strip is a minimally invasive method that captures the stratum corneum. It is use to identify skin biomarkers in atopic dermatitis.

Children with moderate-severe atopic dermatitis

* age 1-8 years old
* moderate or severe degree of atopic dermatitis

Group Type ACTIVE_COMPARATOR

Tape strips

Intervention Type GENETIC

Tape strip is a minimally invasive method that captures the stratum corneum. It is use to identify skin biomarkers in atopic dermatitis.

Children with food allergy and moderate-severe atopic dermatitis

* age 1-8 years old
* moderate or severe degree of atopic dermatitis
* IgE mediated food allergy

Group Type ACTIVE_COMPARATOR

Tape strips

Intervention Type GENETIC

Tape strip is a minimally invasive method that captures the stratum corneum. It is use to identify skin biomarkers in atopic dermatitis.

Adult with atopic dermatitis

* age 18-60 years old
* mild-severe atopic dermatitis

Group Type ACTIVE_COMPARATOR

Tape strips

Intervention Type GENETIC

Tape strip is a minimally invasive method that captures the stratum corneum. It is use to identify skin biomarkers in atopic dermatitis.

Healthy

* age 1-60 years old
* no history of atopic diseases

Group Type ACTIVE_COMPARATOR

Tape strips

Intervention Type GENETIC

Tape strip is a minimally invasive method that captures the stratum corneum. It is use to identify skin biomarkers in atopic dermatitis.

Healthy with Asthma

* age 1-8 years old
* doctor diagnosed asthma
* no history of chronic or chronic relapsing eczema

Group Type ACTIVE_COMPARATOR

Tape strips

Intervention Type GENETIC

Tape strip is a minimally invasive method that captures the stratum corneum. It is use to identify skin biomarkers in atopic dermatitis.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tape strips

Tape strip is a minimally invasive method that captures the stratum corneum. It is use to identify skin biomarkers in atopic dermatitis.

Intervention Type GENETIC

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children (age 1-18 years old) with mild atopic dermatitis
* Children (age 1-18 years old) with moderate to severe atopic dermatitis
* Children (age 1-18 years old) with moderate to severe atopic dermatitis and food allergy
* Adult (age 18-60 years old) with atopic dermatitis
* Healthy individuals (1-60 years old)
* Patients with asthma (1-60 years old)

Exclusion Criteria

* Active skin infections
* Used systemic immunosuppressants within 4 weeks
* Used topical steroids or immunomodulators within 1 week
* Used moisturizers within 12 hours before evaluation
Minimum Eligible Age

1 Year

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mahidol University

OTHER

Sponsor Role collaborator

Icahn School of Medicine at Mount Sinai

OTHER

Sponsor Role collaborator

Samitivej Hospital group

UNKNOWN

Sponsor Role collaborator

Queen Sirikit National Institute of Child Health

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tassalapa Daengsuwan

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Panipak Temboonnark, MD

Role: PRINCIPAL_INVESTIGATOR

Queen Sirikit National Institute of Child Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Queen Sirikit National Institute of Child Health

Bangkok, , Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Panipak Temboonnark, MD

Role: CONTACT

+1929-823-2424

Tassalapa Daengsuwan, MD

Role: CONTACT

+668-1822-1368

References

Explore related publications, articles, or registry entries linked to this study.

Czarnowicki T, He H, Krueger JG, Guttman-Yassky E. Atopic dermatitis endotypes and implications for targeted therapeutics. J Allergy Clin Immunol. 2019 Jan;143(1):1-11. doi: 10.1016/j.jaci.2018.10.032.

Reference Type RESULT
PMID: 30612663 (View on PubMed)

Brunner PM, Guttman-Yassky E. Racial differences in atopic dermatitis. Ann Allergy Asthma Immunol. 2019 May;122(5):449-455. doi: 10.1016/j.anai.2018.11.015. Epub 2018 Nov 20.

Reference Type RESULT
PMID: 30465859 (View on PubMed)

Chan TC, Sanyal RD, Pavel AB, Glickman J, Zheng X, Xu H, Cho YT, Tsai TF, Wen HC, Peng X, Cueto I, Krueger JG, Guttman-Yassky E. Atopic dermatitis in Chinese patients shows TH2/TH17 skewing with psoriasiform features. J Allergy Clin Immunol. 2018 Sep;142(3):1013-1017. doi: 10.1016/j.jaci.2018.06.016. Epub 2018 Jun 28. No abstract available.

Reference Type RESULT
PMID: 29964056 (View on PubMed)

Guttman-Yassky E, Diaz A, Pavel AB, Fernandes M, Lefferdink R, Erickson T, Canter T, Rangel S, Peng X, Li R, Estrada Y, Xu H, Krueger JG, Paller AS. Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis. JAMA Dermatol. 2019 Dec 1;155(12):1358-1370. doi: 10.1001/jamadermatol.2019.2983.

Reference Type RESULT
PMID: 31596431 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

65-007

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Targeted Microbiome Transplant in Atopic Dermatitis
NCT03151148 COMPLETED PHASE1/PHASE2